Abstract
Endoscopic resection and bacillus Calmette-Guérin (BCG) therapy is actually considered as the gold standard in treating superficial bladder transitional cell carcinomas (TCC). Many endoscopic, biological and evolutive parameters are considered as risk factors of recurrence: the prior recurrence rate, number of tumours, tumor size, grade, etc. The objective was to determine if the primary tumor location in the bladder (ureteral meatus) affect long-term outcome after endoscopic resection and intravesical BCG therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
